Brequinar
- Generic Name
- Brequinar
- Drug Type
- Small Molecule
- Chemical Formula
- C23H15F2NO2
- CAS Number
- 96187-53-0
- Unique Ingredient Identifier
- 5XL19F49H6
Brequinar Combined With Dipyridamole in Patients With Mild to Moderate COVID-19
Phase 2
Terminated
- Conditions
- COVID-19
- Interventions
- First Posted Date
- 2021-12-22
- Last Posted Date
- 2023-11-07
- Lead Sponsor
- Clear Creek Bio, Inc.
- Target Recruit Count
- 26
- Registration Number
- NCT05166876
- Locations
- ๐ฎ๐ณ
RIMS - Government Medical College, Srikakulam, Andhra Pradesh, India
๐ฎ๐ณKing George Hospital, Visakhapatnam, Andhra Pradesh, India
๐ฎ๐ณJIPMER Hospital, Pondicherry, Puducherry, India
CRISIS2: A Phase 2 Study of the Safety and Antiviral Activity of Brequinar in Non-hospitalized Pts With COVID-19
- First Posted Date
- 2020-10-05
- Last Posted Date
- 2022-04-19
- Lead Sponsor
- Clear Creek Bio, Inc.
- Target Recruit Count
- 115
- Registration Number
- NCT04575038
- Locations
- ๐บ๐ธ
Synexus Clinical Research US, Inc. - Olympus Family Medicine, Salt Lake City, Utah, United States
๐บ๐ธArk Clinical Research, Long Beach, California, United States
๐บ๐ธCentral Alabama Research, Homewood, Alabama, United States
Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19
- First Posted Date
- 2020-06-11
- Last Posted Date
- 2022-02-17
- Lead Sponsor
- Clear Creek Bio, Inc.
- Target Recruit Count
- 25
- Registration Number
- NCT04425252
- Locations
- ๐บ๐ธ
University of South Florida/Tampa General, Tampa, Florida, United States
๐บ๐ธHartford Hospital, Hartford, Connecticut, United States
๐บ๐ธTemple University, Philadelphia, Pennsylvania, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
ยฉ Copyright 2025. All Rights Reserved by MedPath